If you have reached menopause, your healthcare team may offer you the option to continue tamoxifen for up to 10 years in total or to switch to an aromatase inhibitor for up to 5 years for up to a total of 10 years of hormonal therapy. During the early years of the study period, tamoxifen was not routinely given to premenopausal women . Dimpling of the skin and nipple retraction is not the same as inflammatory breast cancer and may occur in any T-stage without affecting the classification. Clinical features and patterns of recurrence. Neoadjuvant chemotherapy from neo:
The choice of therapy depends on: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Stage IV describes invasive breast cancer that has spread beyond the breast and nearby lymph nodes to other organs of the body, such as the lungs, distant lymph nodes, skin, bones, liver, or brain. Targeted therapy Trastuzumab Herceptin is added to chemotherapy for stage 2 breast cancer that is HER2-positive and has a high risk for recurrence. How to cite this article.
Treatments for stage 2 breast cancer - Canadian Cancer Society
I had a normal mammogram two years earlier. In this patient, there are two groups of suspicious calcifications which are about 5 cm apart. Ergo, my four-centimeter lump cannot be cancer. It may have also spread to the internal mammary lymph nodes. If you are still premenopausal, you can continue to take tamoxifen for up to 10 years in total.
Figure 1 illustrates the relationship further: Treatment depends on many factors, including the stage of breast cancer, family history, genetics and a person's personal preferences. An error has occurred. Medical Illustrations. Click image to enlarge.